In Vitro Activity of a Novel Diaminopyrimidine Compound, Iclaprim, against Chlamydia trachomatis and C. pneumoniae

The in vitro activities of iclaprim, a novel dihydrofolate reductase inhibitor, azithromycin, and levofloxacin were tested against 10 strains of Chlamydia trachomatis and 10 isolates of Chlamydia pneumoniae. For C. trachomatis and C. pneumoniae, the iclaprim MIC and minimal bactericidal concentratio...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kohlhoff, S. A., Roblin, P. M., Reznik, T., Hawser, S., Islam, K., Hammerschlag, M. R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2004
Gaiak:
Susceptibility
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC400585/
https://ncbi.nlm.nih.gov/pubmed/15105151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1885-1886.2004
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak